Serine racemase is associated with schizophrenia susceptibility in humans and in a mouse model.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Human Molecular Genetics

• Publication date

  2009-09-01

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.1093/hmg/ddp261PMID 19483194PMCID PMC2722985
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Assessment of Glutamate Transporter GLAST (EAAT1)-Deficient Mice for Phenotypes Relevant to the Negative and Executive/Cognitive Symptoms of Schizophrenia

  2009cited by this paper
• Recombinant human serine racemase: enzymologic characterization and comparison with its mouse ortholog.

  2009cited by this paper
• Mutant mice with reduced NMDA-NR1 glycine affinity or lack of D-amino acid oxidase function exhibit altered anxiety-like behaviors.

  2009cited by this paper
• Genetic inactivation of D-amino acid oxidase enhances extinction and reversal learning in mice.

  2008cited by this paper
• Transcriptomic responses to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in liver: Comparison of rat and mouse

  2008cited by this paper
• Mice with reduced NMDA receptor glycine affinity model some of the negative and cognitive symptoms of schizophrenia

  2008cited by this paper
• Serum‐ and glucocorticoid‐inducible kinase 1 enhances zif268 expression through the mediation of SRF and CREB1 associated with spatial memory formation

  2008cited by this paper
• D-Serine Augments NMDA-NR2B Receptor-Dependent Hippocampal Long-Term Depression and Spatial Reversal Learning

  2008cited by this paper
• Changes in plasma glycine, L-serine, and D-serine levels in patients with schizophrenia as their clinical symptoms improve: results from the Juntendo University Schizophrenia Projects (JUSP).

  2008cited by this paper
• Beta N‐acetylglucosaminyltransferase V (Mgat5) deficiency reduces the depression‐like phenotype in mice

  2008cited by this paper
• Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior

  2008cited by this paper
• Neurological soft signs as candidate endophenotypes for schizophrenia: a shooting star or a Northern star?

  2008cited by this paper
• Increased brain D-amino acid oxidase (DAAO) activity in schizophrenia.

  2008cited by this paper
• Hypothalamic Preproghrelin Gene Expression Is Repressed by Insulin via Both PI3-K/Akt and ERK1/2 MAPK Pathways in Immortalized, Hypothalamic Neurons

  2008cited by this paper
• Trends in large-scale mouse mutagenesis: from genetics to functional genomics

  2008cited by this paper
• Effect of MK‐801 on gene expressions in the amygdala of rats

  2008cited by this paper
• In vitro and in vivo pharmacological profile of AS057278, a selective d-amino acid oxidase inhibitor with potential anti-psychotic properties.

  2008cited by this paper
• d‐Amino acids in the brain: d‐serine in neurotransmission and neurodegeneration

  2008cited by this paper
• No association between the serine racemase gene (SRR) and schizophrenia in a German case-control sample.

  2007influential reference
• A CSF and postmortem brain study of D-serine metabolic parameters in schizophrenia.

  2007cited by this paper
• D‐Serine is a key determinant of glutamate toxicity in amyotrophic lateral sclerosis

  2007cited by this paper
• Phenotypic characterization of spatial cognition and social behavior in mice with 'knockout' of the schizophrenia risk gene neuregulin 1.

  2007cited by this paper
• Effects of MK-801 on the expression of serine racemase and d-amino acid oxidase mRNAs and on the D-serine levels in rat brain.

  2007cited by this paper
• D-serine regulates CREB phosphorylation induced by NMDA receptor activation in Müller glia from the retina.

  2007cited by this paper
• beadarray: R classes and methods for Illumina bead-based data

  2007cited by this paper
• Improvement and decline of cognitive function in schizophrenia over one year: a longitudinal investigation using latent growth modelling

  2007cited by this paper
• What's wrong with capacity? Capacity as the test of compulsion

  2007cited by this paper
• Evidence for association and epistasis at the DAOA/G30 and D‐amino acid oxidase loci in an Irish schizophrenia sample

  2007cited by this paper
• A genetic variant of the serine racemase gene is associated with schizophrenia.

  2007influential reference
• Associations of blood levels of insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-3 in schizophrenic Arab subjects.

  2007cited by this paper
• Transcriptional response to the neuroleptic‐like compound Ampullosporin A in the rat ketamine model

  2006cited by this paper
• Cure therapeutics and strategic prevention: raising the bar for mental health research

  2006cited by this paper
• Disease Biomarkers in Cerebrospinal Fluid of Patients with First-Onset Psychosis

  2006cited by this paper
• Ventral Neural Progenitors Switch toward an Oligodendroglial Fate in Response to Increased Sonic Hedgehog (Shh) Activity: Involvement of Sulfatase 1 in Modulating Shh Signaling in the Ventral Spinal Cord

  2006cited by this paper
• Immunocytochemical analysis of D‐serine distribution in the mammalian brain reveals novel anatomical compartmentalizations in glia and neurons

  2006cited by this paper
• Expression of the mRNA and protein of serine racemase in primary cultures of rat neurons.

  2006cited by this paper
• Glia-derived D-serine controls NMDA receptor activity and synaptic memory.

  2006cited by this paper
• Glutamate and Schizophrenia: Beyond the Dopamine Hypothesis

  2006cited by this paper
• Serine racemase binds to PICK1: potential relevance to schizophrenia

  2006cited by this paper
• Pharmacological treatment of primary negative symptoms in schizophrenia: a systematic review.

  2006cited by this paper
• Lamina‐specific abnormalities of AMPA receptor trafficking and signaling molecule transcripts in the prefrontal cortex in schizophrenia

  2006cited by this paper
• Pathophysiologically based treatment interventions in schizophrenia

  2006cited by this paper
• Polymorphism in the 5′-promoter region of serine racemase gene in schizophrenia

  2006cited by this paper
• D-serine signalling in the brain: friend and foe.

  2006cited by this paper
• N-methyl-D-aspartate receptor NR2B subunit gene GRIN2B in schizophrenia and bipolar disorder: Polymorphisms and mRNA levels.

  2006cited by this paper
• The schizophrenic faces of PICK1.

  2006cited by this paper
• Modeling madness in mice: one piece at a time.

  2006cited by this paper
• Neurobiology of schizophrenia.

  2006cited by this paper
• The pharmacological stimulation of NMDA receptors via co-agonist site: an fMRI study in the rat brain.

  2005cited by this paper
• Efficient gene-driven germ-line point mutagenesis of C57BL/6J mice

  2005cited by this paper
• Regulation of serine racemase activity by amino acids.

  2005cited by this paper
• Serine racemase: activation by glutamate neurotransmission via glutamate receptor interacting protein and mediation of neuronal migration.

  2005cited by this paper
• Molecular characterization of ENU mouse mutagenesis and archives.

  2005influential reference
• D-Serine Is the Dominant Endogenous Coagonist for NMDA Receptor Neurotoxicity in Organotypic Hippocampal Slices

  2005cited by this paper
• Modulators of the glycine site on NMDA receptors, d-serine and ALX 5407, display similar beneficial effects to clozapine in mouse models of schizophrenia

  2005cited by this paper
• Identification of multiple serine racemase (SRR) mRNA isoforms and genetic analyses of SRR and DAO in schizophrenia and D-serine levels.

  2005cited by this paper
• Serine Racemase Modulates Intracellular D-Serine Levels through an α,β-Elimination Activity*

  2005cited by this paper
• Serine racemase modulates intracellular D-serine levels through an alpha,beta-elimination activity.

  2005cited by this paper
• D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia.

  2005cited by this paper
• Genetic and post-mortem mRNA analysis of the 14-3-3 genes that encode phosphoserine/threonine-binding regulatory proteins in schizophrenia and bipolar disorder.

  2005cited by this paper
• D-amino acids in the central nervous system in health and disease.

  2005cited by this paper
• Social approach-avoidance behavior of inbred mouse strains towards DBA/2 mice.

  2004cited by this paper
• Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder

  2004cited by this paper
• A gene for neuronal plasticity in the mammalian brain: Zif268/Egr-1/NGFI-A/Krox-24/TIS8/ZENK?

  2004cited by this paper
• Induction of serine racemase expression and D-serine release from microglia by amyloid β-peptide

  2004cited by this paper
• Repeated administration of phencyclidine, amphetamine and MK-801 selectively impairs spatial learning in mice: a possible model of psychotomimetic drug-induced cognitive deficits

  2003cited by this paper
• Cognition impairment in the genetic model of aging klotho gene mutant mice: a role of oxidative stress

  2003cited by this paper
• White matter changes in schizophrenia: evidence for myelin-related dysfunction.

  2003cited by this paper
• Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia.

  2003cited by this paper
• Spatiotemporal relationships among D-serine, serine racemase, and D-amino acid oxidase during mouse postnatal development.

  2003cited by this paper
• D-Cycloserine added to risperidone in patients with primary negative symptoms of schizophrenia.

  2002cited by this paper
• Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia.

  2002cited by this paper
• Hippocampal damage and exploratory preferences in rats: memory for objects, places, and contexts.

  2002cited by this paper
• Vasopressin V1b receptor knockout reduces aggressive behavior in male mice

  2002cited by this paper
• Lower prolactin bioactivity in unmedicated schizophrenic patients.

  2001cited by this paper
• Neurogranin null mutant mice display performance deficits on spatial learning tasks with anxiety related components

  2001cited by this paper
• Validation of array-based gene expression profiles by real-time (kinetic) RT-PCR.

  2001cited by this paper
• Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review

  2001cited by this paper
• Animal models for the negative symptoms of schizophrenia

  2000cited by this paper
• Neurobiology of schizophrenia

  2000cited by this paper
• NMDA receptor mediated changes in IGF‐II gene expression in the rat brain after injury and the possible role of nitric oxide

  2000cited by this paper
• Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia.

  1999cited by this paper
• Purification of serine racemase: biosynthesis of the neuromodulator D-serine.

  1999cited by this paper
• Effects of lesions to the glutamatergic afferents to the nucleus accumbens in the modulation of reactivity to spatial and non-spatial novelty in mice.

  1999cited by this paper
• D-serine added to antipsychotics for the treatment of schizophrenia.

  1998cited by this paper
• d-Serine as a Neuromodulator: Regional and Developmental Localizations in Rat Brain Glia Resemble NMDA Receptors

  1997cited by this paper
• Interactions between N-methyl-D-aspartate, nitric oxide and serotonin in the control of prolactin secretion in prepubertal male rats.

  1997cited by this paper
• Neurocognitive deficits and neurological signs in schizophrenia.

  1997cited by this paper
• Selective deficits in visual perception and recognition in schizophrenia.

  1996cited by this paper
• Involvement of glutamatergic and dopaminergic systems in the reactivity of mice to spatial and non-spatial change

  1996cited by this paper
• Formation of d‐Serine from l‐Phosphoserine in Brain Synaptosomes

  1996cited by this paper
• Functional Comparison of d‐Serine and Glycine in Rodents: The Effect on Cloned NMDA Receptors and the Extracellular Concentration

  1995cited by this paper
• Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.

  1994cited by this paper
• Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients.

  1994cited by this paper
• Targeted disruption of NMDA receptor 1 gene abolishes NMDA response and results in neonatal death.

  1994cited by this paper
• Biological role of D-amino acid oxidase and D-aspartate oxidase. Effects of D-amino acids.

  1993cited by this paper
• Gating and habituation of the startle reflex in schizophrenic patients.

  1992cited by this paper
• Activation kinetics reveal the number of glutamate and glycine binding sites on the N-methyl-D-aspartate receptor.

  1991cited by this paper
• A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies.

  1991cited by this paper
• Recent advances in the phencyclidine model of schizophrenia.

  1991cited by this paper

• Physiological Roles of Hydrogen Sulfide/Polysulfides and Regulation of their Production.

  2026cites this paper
• Negr1 deficiency alters glutamate signalling and kynurenine pathway in a mouse model of psychiatric disorders

  2026cites this paper
• Serine metabolism in the central nervous system: advances and challenges on a conditionally essential amino acid.

  2025cites this paper
• Neural Metabolic Networks: Key Elements of Healthy Brain Function

  2025cites this paper
• Impact of D-Amino Acids in Schizophrenia

  2025cites this paper
• Prefrontal cortex cytosolic and synaptosome proteome reveal molecular signatures of resilience to chronic social isolation stress in rats

  2025cites this paper
• A new 2-hit model combining serine racemase deletion and maternal separation displays behavioral and cognitive deficits associated with schizophrenia.

  2024cites this paper
• Decreased free D-aspartate levels in the blood serum of patients with schizophrenia

  2024cites this paper
• Biosynthesis and Degradation of Free D-Amino Acids and Their Physiological Roles in the Periphery and Endocrine Glands.

  2024cites this paper
• Roles of serine in neurodegenerative diseases

  2023cites this paper
• In Silico and In Vitro Screening of Serine Racemase Agonist and In Vivo Efficacy on Alzheimer’s Disease Drosophila melanogaster

  2023cites this paper
• ASC Transporters Mediate D-Serine Transport into Astrocytes Adjacent to Synapses in the Mouse Brain

  2023cites this paper
• Cross species review of the physiological role of d-serine in translationally relevant behaviors

  2023influential citation
• Hydrogen sulfide and polysulfides induce GABA/glutamate/d-serine release, facilitate hippocampal LTP, and regulate behavioral hyperactivity

  2023cites this paper
• Kaleidoscope: A Bioinformatics Web Application for In Silico Exploration of Omics Data

  2023cites this paper
• The Role of D-Serine and D-Aspartate in the Pathogenesis and Therapy of Treatment-Resistant Schizophrenia

  2022cites this paper
• Endogenous d-serine exists in the mammalian brain independent of synthesis by serine racemase.

  2022cites this paper
• Olfactory Dysfunction in Schizophrenia: Evaluating Olfactory Abilities Across Species.

  2022cites this paper
• Beyond NMDA Receptors: Homeostasis at the Glutamate Tripartite Synapse and Its Contributions to Cognitive Dysfunction in Schizophrenia

  2022cites this paper
• Serine racemase expression differentiates aging from Alzheimer's brain.

  2022cites this paper
• Deletion of serine racemase reverses neuronal insulin signaling inhibition by amyloid‐β oligomers

  2022cites this paper
• Rational and Translational Implications of D-Amino Acids for Treatment-Resistant Schizophrenia: From Neurobiology to the Clinics

  2022cites this paper
• Effects of Quinolinate-Induced Lesion of the Medial Prefrontal Cortex on Prefrontal and Striatal Concentrations of d-Serine in the Rat

  2022cites this paper
• D-serine metabolism in the medial prefrontal cortex, but not the hippocampus, is involved in AD/HD-like behaviors in SHRSP/Ezo.

  2022cites this paper
• Excitatory drive of cortical fast-spiking GABAergic interneurons is set by D-serine acting on NMDA receptors

  2022cites this paper
• Alterations of serine racemase expression determine proliferation and differentiation of neuroblastoma cells

  2022cites this paper
• Reduced d-serine levels drive enhanced non-ionotropic NMDA receptor signaling and destabilization of dendritic spines in a mouse model for studying schizophrenia

  2022cites this paper
• Functional genomics of psychiatric disease risk using genome engineering

  2021cites this paper
• d-Amino Acids and pLG72 in Alzheimer’s Disease and Schizophrenia

  2021cites this paper
• Chronic Cerebral Toxoplasmosis Changes Brain Glutamate and D-Serine Levels, Impairs Startle Reflex But Not Social Preference in Mice

  2021cites this paper
• NMDARs, Coincidence Detectors of Astrocytic and Neuronal Activities

  2021cites this paper
• D-serine induces distinct transcriptomes in diverse Escherichia coli pathotypes

  2021cites this paper
• D-cysteine is an endogenous regulator of neural progenitor cell dynamics in the mammalian brain

  2021cites this paper
• Timing of maternal immune activation and sex influence schizophrenia-relevant cognitive constructs and neuregulin and GABAergic pathways.

  2021cites this paper
• A Rationally and Computationally Designed Fluorescent Biosensor for d-Serine.

  2021cites this paper
• D-Serine: Basic Aspects with a Focus on Psychosis

  2021cites this paper
• Social preference is maintained in mice with impaired startle reflex and glutamate/D-serine imbalance induced by chronic cerebral toxoplasmosis

  2021cites this paper
• Sp4 controls constitutive expression of neuronal serine racemase and NF-E2-related factor-2 mediates its induction by valproic acid.

  2020cites this paper
• L-Serine links metabolism with neurotransmission.

  2020cites this paper
• A computationally designed fluorescent biosensor for D-serine

  2020cites this paper
• Serine Racemase Deletion Affects the Excitatory/Inhibitory Balance of the Hippocampal CA1 Network

  2020cites this paper
• The origin of NMDA receptor hypofunction in schizophrenia.

  2020cites this paper
• Electroretinographic Abnormalities and Sex Differences Detected with Mesopic Adaptation in a Mouse Model of Schizophrenia: A and B Wave Analysis

  2020cites this paper
• Kaleidoscope: A New Bioinformatics Pipeline Web Application for In Silico Hypothesis Exploration of Omics Signatures

  2020cites this paper
• Auditory cognitive training improves prepulse inhibition in serine racemase mutant mice

  2020influential citation
• Developmental alterations in the transcriptome of three distinct rodent models of schizophrenia

  2020cites this paper
• Is serine racemase (SRR) a second hit target for LRRK2-G2019S induced Parkinson’s disease?

  2020cites this paper
• An Overview of Animal Models Related to Schizophrenia

  2019cites this paper
• D-Serine: Potential Therapeutic Agent and/or Biomarker in Schizophrenia and Depression?

  2019cites this paper
• The Energy Landscape of Human Serine Racemase

  2019cites this paper
• D-Serine made by serine racemase in Drosophila intestine plays a physiological role in sleep

  2019cites this paper
• Intravenous injection of l‐aspartic acid &bgr;‐hydroxamate attenuates choroidal neovascularization via anti‐VEGF and anti‐inflammation

  2019cites this paper
• Comprehensive functional annotation of susceptibility SNPs prioritized 10 genes for schizophrenia

  2019cites this paper
• Glutamine 89 is a key residue in the allosteric modulation of human serine racemase activity by ATP

  2018cites this paper
• Loss‐of‐function mutation of serine racemase attenuates retinal ganglion cell loss in diabetic mice

  2018cites this paper
• Chronic d-serine supplementation impairs insulin secretion

  2018cites this paper
• Changes in Serine Racemase-Dependent Modulation of NMDA Receptor: Impact on Physiological and Pathological Brain Aging

  2018cites this paper
• d-Serine is a potential biomarker for clinical response in treatment of post-traumatic stress disorder using (R,S)-ketamine infusion and TIMBER psychotherapy: A pilot study.

  2018cites this paper
• Deletion of serine racemase confers D‐serine –dependent resilience to chronic social defeat stress

  2018cites this paper
• Potential and Challenges for the Clinical Use of d-Serine As a Cognitive Enhancer

  2018cites this paper
• The Neurobiology of d-Serine Signaling.

  2018cites this paper
• Tissue expression and source of circulating αKlotho.

  2017cites this paper
• Ketamine: An Update on Cellular and Subcellular Mechanisms with Implications for Clinical Practice.

  2017cites this paper
• Faster progression from MCI to probable AD for carriers of a single-nucleotide polymorphism associated with type 2 diabetes.

  2017cites this paper
• Serine racemase deficiency attenuates choroidal neovascularization and reduces nitric oxide and VEGF levels by retinal pigment epithelial cells

  2017cites this paper
• Genetic Biomarkers on Age-Related Cognitive Decline

  2017cites this paper
• Identification of a Bipolar Disorder Vulnerable Gene CHDH at 3p21.1

  2017cites this paper
• Design, synthesis, and evaluation of novel inhibitors for wild-type human serine racemase.

  2017cites this paper
• Developmental and genetic regulation of the human cortex transcriptome in schizophrenia

  2017cites this paper
• QKI6B mRNA levels are upregulated in schizophrenia and predict GFAP expression.

  2017cites this paper
• Potential role of amino acids in pathogenesis of schizophrenia

  2017cites this paper
• Evidence for Tonic Control by the GABAA Receptor of Extracellular D-Serine Concentrations in the Medial Prefrontal Cortex of Rodents

  2017cites this paper
• Forward and Reverse Genetics to Model Human Diseases in the Mouse

  2017cites this paper
• Defects in Bioenergetic Coupling in Schizophrenia.

  2017cites this paper
• Translational potential of astrocytes in brain disorders.

  2016cites this paper
• d-Serine Signaling and Schizophrenia

  2016cites this paper
• A Novel Relationship for Schizophrenia, Bipolar, and Major Depressive Disorder. Part 8: a Hint from Chromosome 8 High Density Association Screen

  2016cites this paper
• Serine Racemase Knockout Mice: Neurotoxicity, Epilepsy, and Schizophrenia

  2016cites this paper
• Disrupted‐in‐schizophrenia‐1 as a broader link of glutamatergic transmission to schizophrenia impacts cerebral neurochemistry via the production of the ‘gliotransmitter’ d‐serine, a NMDA receptor coagonist

  2016cites this paper
• Astrogliopathology in neurological, neurodevelopmental and psychiatric disorders.

  2016cites this paper
• D-Amino Acids in the Nervous and Endocrine Systems

  2016cites this paper
• Developmental and genetic regulation of the human cortex transcriptome in schizophrenia 1 2

  2016cites this paper
• Astroglia, Glutamatergic Transmission and Psychiatric Diseases.

  2016cites this paper
• The Reciprocal Effects of Oxidative Stress and Glutamate Neurotransmission

  2015cites this paper
• Schizophrenia and Depression Co-Morbidity: What We have Learned from Animal Models

  2015cites this paper
• Glia‐related genes and their contribution to schizophrenia

  2015cites this paper
• d‐amino acid oxidase knockout (Dao −/−) mice show enhanced short‐term memory performance and heightened anxiety, but no sleep or circadian rhythm disruption

  2015influential citation
• Interlocus gene conversion explains at least 2.7 % of single nucleotide variants in human segmental duplications

  2015cites this paper
• Functional alterations of astrocytes in mental disorders: pharmacological significance as a drug target

  2015cites this paper
• Nuclear Compartmentalization of Serine Racemase Regulates d-Serine Production

  2015cites this paper
• Reduced serine racemase expression in aging rat cerebellum is associated with oxidative DNA stress and hypermethylation in the promoter.

  2015cites this paper
• Loss‐of‐function mutation of serine racemase attenuates excitotoxicity by intravitreal injection of N‐methyl‐D‐aspartate

  2015cites this paper
• D-serine prevents cognitive deficits induced by acute stress.

  2014influential citation
• D-Serine in Neuropsychiatric Disorders: New Advances

  2014cites this paper
• Astrogliopathology

  2014cites this paper
• D-Serine in Neurobiology: CNS Neurotransmission and Neuromodulation

  2014cites this paper
• Increased Sensitivity to Inflammatory Pain Induced by Subcutaneous Formalin Injection in Serine Racemase Knock-Out Mice

  2014cites this paper
• Disrupted-In-Schizophrenia-1 (DISC1) interactome and mental disorders: impact of mouse models.

  2014cites this paper
• FBXO22 Protein Is Required for Optimal Synthesis of the N-Methyl-d-Aspartate (NMDA) Receptor Coagonist d-Serine*

  2014cites this paper
• Novel Targets for Development of Drugs for Treating Schizophrenia: Focus on Glycine, D-Serine and Nitric Oxide

  2013cites this paper